BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1895405)

  • 1. Moloney leukemia virus immortalizes B lymphocytes in vitro.
    Runnels J; Serunian L; Thursby M; Rosenberg N
    J Virol; 1991 Oct; 65(10):5549-52. PubMed ID: 1895405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome organization of retroviruses. VIII. Nonproducer cell lines of mouse fibroblasts transformed by Moloney murine sarcoma virus DNA synthesized in vitro.
    Lai MH; Verma IM
    Virology; 1980 Jul; 104(2):407-17. PubMed ID: 7395109
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of retroviral vectors to study cell transformation and malignancy.
    Symonds G; Bonham L; Chisholm O; Miller M; Stapleton P; Takayama Y
    Transplant Proc; 1989 Feb; 21(1 Pt 1):61-4. PubMed ID: 2705240
    [No Abstract]   [Full Text] [Related]  

  • 4. Partial characterization of a moloney murine sarcoma virus 85,000-dalton polypeptide whose expression correlates with the transformed phenotype in cells infected with a temperature-sensitive mutant virus.
    Horn JP; Wood TG; Blair DG; Arlinghaus RB
    Virology; 1980 Sep; 105(2):516-25. PubMed ID: 7423857
    [No Abstract]   [Full Text] [Related]  

  • 5. Generation and characterization of a recombinant Moloney murine leukemia virus containing the v-myc oncogene of avian MC29 virus: in vitro transformation and in vivo pathogenesis.
    Brightman BK; Pattengale PK; Fan H
    J Virol; 1986 Oct; 60(1):68-81. PubMed ID: 3018301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective temperature-sensitive defect in viral RNA expression in cells infected with a ts transformation mutant of murine sarcoma virus.
    Horn JP; Wood TG; Murphy EC; Blair DG; Arlinghaus RB
    Cell; 1981 Jul; 25(1):37-46. PubMed ID: 7273137
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of interferon effects on murine leukemia virus (MuLV)-infected cells.
    Pitha PM
    Methods Enzymol; 1981; 79(Pt B):422-32. PubMed ID: 6173690
    [No Abstract]   [Full Text] [Related]  

  • 8. The integration sites of endogenous and exogenous Moloney murine leukemia virus.
    van der Putten H; Terwindt E; Berns A; Jaenisch R
    Cell; 1979 Sep; 18(1):109-16. PubMed ID: 509516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of naturally occuring deletion mutants of Moloney murine sarcoma virus.
    Canaani E; Aaronson SA
    Virology; 1980 Sep; 105(2):456-66. PubMed ID: 7423856
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression of murine retrovirus polypeptide termination: effect of amber suppressor tRNA on the cell-free translation of Rauscher murine leukemia virus, Moloney murine leukemia virus, and Moloney murine sarcoma virus 124 RNA.
    Murphy EC; Wills N; Arlinghaus RB
    J Virol; 1980 May; 34(2):464-73. PubMed ID: 7373716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of virus-specified proteins present in NRK cells infected with a temperature-sensitive transformation mutant of Moloney murine sarcoma virus.
    Wood TG; Peltier-Horn J; Robey WG; Blair DG; Arlinghaus RB
    Cold Spring Harb Symp Quant Biol; 1980; 44 Pt 2,():747-54. PubMed ID: 6253209
    [No Abstract]   [Full Text] [Related]  

  • 12. Generation of a recombinant Moloney murine leukemia virus carrying the v-src gene of avian sarcoma virus: transformation in vitro and pathogenesis in vivo.
    Feuerman MH; Davis BR; Pattengale PK; Fan H
    J Virol; 1985 Jun; 54(3):804-16. PubMed ID: 2987532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins.
    Crawford S; Goff SP
    J Virol; 1985 Mar; 53(3):899-907. PubMed ID: 3882995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UAG readthrough is not increased in vivo by Moloney murine leukemia virus infection.
    Berteaux V; Rousset JP; Cassan M
    Biochimie; 1991 Oct; 73(10):1291-3. PubMed ID: 1782222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T and B lymphocyte susceptibility to murine leukemia virus moloney.
    Isaak DD; Cerny J
    Infect Immun; 1983 Jun; 40(3):977-84. PubMed ID: 6602095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence for deletion of envelope glycoprotein (gp69/71) sequences in formation of Moloney-murine sarcoma virus.
    Peebles PT; Strand M; August JT
    J Gen Virol; 1978 Sep; 40(3):503-10. PubMed ID: 80447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome organization of retroviruses. VII. Infection by double-stranded DNA synthesized in vitro from Moloney murine leukemia virus generates a virus indistinguishable from the original virus used in reverse transcription.
    Lai MH; Verma IM
    Virology; 1980 Jan; 100(1):194-8. PubMed ID: 6153135
    [No Abstract]   [Full Text] [Related]  

  • 18. The long terminal repeat negative control region is a critical element for insertional oncogenesis after gene transfer into hematopoietic progenitors with Moloney murine leukemia viral vectors.
    Ikawa Y; Uchiyama T; Jagadeesh GJ; Candotti F
    Gene Ther; 2016 Nov; 23(11):815-818. PubMed ID: 27487944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of a mouse cell line containing a defective Moloney murine leukemia virus genome.
    Besmer P; Fan H; Paskind M; Baltimore D
    J Virol; 1979 Mar; 29(3):1023-34. PubMed ID: 221665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of polycythemia-inducing Friend leukemia virus and Moloney leukemia virus on hematopoietic progenitors in murine long-term bone marrow cultures.
    Heard JM; Fichelson S; Gisselbrecht S; Varet B
    Cancer Res; 1981 Aug; 41(8):3260-5. PubMed ID: 6972804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.